Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

DBT-TOBI Scan in Monitoring Response to Chemotherapy before Surgery in Patients with HER2 Positive or Triple Negative Breast Cancer

Trial Status: closed to accrual

This trial studies how well digital breast tomosynthesis guided near-infrared tomographic optical breast imaging (DBT-TOBI) scan works in monitoring response to chemotherapy before surgery in patients with HER2 positive or triple negative breast cancer. The DBT-TOBI scan system is designed to deliver low power laser lights through a person’s body tissue and collect data about the light that is transmitted through. The data that can be collected through the scan is the total hemoglobin concentration and hemoglobin oxygen saturation. Hemoglobin is the protein found in red blood cells that is responsible for carrying oxygen to the various tissues in the body. These two data types may provide insight into the response of the breast cancer to chemotherapy before surgery.